Eisai Says First-Half Profit Fell 17% to 33.3 Billion Yen

Nov. 1 (Bloomberg) -- Eisai Co., the maker of the Aricept treatment for Alzheimer’s disease, reported first-half profit fell 17 percent to 33.3 billion yen in a statement to the Tokyo Stock Exchange today.

To contact the reporter on this story: Kanoko Matsuyama in Tokyo at kmatsuyama2@bloomberg.net

To contact the editor responsible for this story: Jason Gale at j.gale@bloomberg.net